Literature DB >> 16181205

A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.

Günther F Körmöczi1, Christoph Gassner, Chao-Peng Shao, Makoto Uchikawa, Tobias J Legler.   

Abstract

BACKGROUND: The D antigen of the polymorphic Rh blood group system is of particular clinical importance regarding transfusion- and pregnancy-induced alloimmunization. Different RhD variants with specific clinical implications have been characterized. The least expressed D variants collectively called DEL are serologically detectable only by adsorption-elution techniques, with so far only poorly defined antigenic properties. STUDY DESIGN AND METHODS: A comprehensive immunohematologic analysis of five of the six currently known DEL genotypes was performed. DEL phenotypes associated with the RHD(M295I), RHD(IVS3+1g>a), RHD(K409K), RHD(X418L), or RHD(IVS5-38del4) allele were characterized with extended serology and flow cytometry.
RESULTS: Epitope mapping with adsorption-elution revealed a prominent D epitope loss in the RHD(IVS3+1g>a)-associated DEL phenotype, whereas in the other four DEL types no signs of qualitative D antigen alteration were detected. The observation of alloanti-D in two RHD(IVS3+1g>a) cases confirmed the partial nature of this DEL phenotype. The RHD(M295I) phenotype exhibited the highest D antigen expression among all investigated DEL types, as determined by a semiquantitative adsorption-elution approach and flow cytometry.
CONCLUSION: In conclusion, evidence is provided that different DEL genotypes code either for partial or complete D antigen expression and that this finding is clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181205     DOI: 10.1111/j.1537-2995.2005.00584.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  23 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA.

Authors:  Mariza Mota; M Dezan; M C Valgueiro; A M Sakashita; J M Kutner; L Castilho
Journal:  J Clin Lab Anal       Date:  2012-02       Impact factor: 2.352

3.  Analysis of density and epitopes of D antigen on the surface of erythrocytes from DEL phenotypic individuals carrying the RHD1227A allele.

Authors:  Juan Gu; An-Yuan Sun; Xue-Dong Wang; Chao-Peng Shao; Zheng Li; Li-Hua Huang; Zhao-Lin Pan; Qing-Ping Wang; Guang-Ming Sun
Journal:  Blood Transfus       Date:  2013-11-21       Impact factor: 3.443

4.  DEL.

Authors:  Willy Albert Flegel; Franz Friedrich Wagner
Journal:  Blood Transfus       Date:  2020-03-17       Impact factor: 3.443

5.  The synonymous nucleotide substitution RHD 1056C>G alters mRNA splicing associated with serologically weak D phenotype.

Authors:  Sejong Chun; Jae Won Yun; Geon Park; Duck Cho
Journal:  J Clin Lab Anal       Date:  2017-09-19       Impact factor: 2.352

6.  Prospective Evaluation of a Transfusion Policy of RhD-Positive Red Blood Cells into DEL Patients in China.

Authors:  Wei Xu; Mei Zhu; Bao-Long Wang; Hong Su; Min Wang
Journal:  Transfus Med Hemother       Date:  2014-12-22       Impact factor: 3.747

7.  Application of a Multivariant, Caucasian-Specific, Genotyped Donor Panel for Performance Validation of MDmulticard®, ID-System®, and Scangel® RhD/ABO Serotyping.

Authors:  Christoph Gassner; Esther Rainer; Elfriede Pircher; Lydia Markut; Günther F Körmöczi; Christof Jungbauer; Dietmar Wessin; Roswitha Klinghofer; Harald Schennach; Peter Schwind; Diether Schönitzer
Journal:  Transfus Med Hemother       Date:  2009-05-18       Impact factor: 3.747

8.  The Bloodgen Project of the European Union, 2003-2009.

Authors:  Neil D Avent; Antonio Martinez; Willy A Flegel; Martin L Olsson; Marion L Scott; Núria Nogués; Martin Písăcka; Geoff L Daniels; Eduardo Muñiz-Diaz; Tracey E Madgett; Jill R Storry; Sigrid Beiboer; Petra M Maaskant-van Wijk; Inge von Zabern; Elisa Jiménez; Diego Tejedor; Monica López; Emma Camacho; Goedele Cheroutre; Anita Hacker; Pavel Jinoch; Irena Svobodova; Ellen van der Schoot; Masja de Haas
Journal:  Transfus Med Hemother       Date:  2009-05-28       Impact factor: 3.747

9.  DEL phenotype.

Authors:  Dong H Kwon; S G Sandler; Willy A Flegel
Journal:  Immunohematology       Date:  2017-09

10.  An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.

Authors:  Qing-Ping Wang; Guang-Tao Dong; Xue-Dong Wang; Juan Gu; Zheng Li; An-Yuan Sun; Chao-Peng Shao; Zhao-Lin Pan; Li-Hua Huang; Wei-Xing Xie; Guang-Ming Sun; Jian-Jiang Chen; Hao Pei; Xiao-Juan Yang; Ping-Nan Shan
Journal:  Blood Transfus       Date:  2013-02-06       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.